Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical Business and Bio Business divisions. The Pharmaceutical Business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio Business division manufactures biopharmaceuticals.
The company was founded on December 3, 1960 and is headquartered in Seoul, South Korea.
The company is a biopharmaceutical company that is currently in the scale-up stage of growth. They have established themselves as a leader in developing innovative and revolutionary protein drug development technologies, as well as highly efficient production capabilities. The company has been expanding its operations and market presence, aiming to solidify its position as a key player in the biopharmaceutical industry.
The company has achieved significant milestones in its history, including successful revenue growth year over year. They have penetrated new markets and expanded their customer base globally, forming strategic partnerships with key stakeholders in the industry. Additionally, the company has received recognition for its groundbreaking research and development in biologics and other related fields.
The company has been involved in several notable case studies and significant projects, showcasing the impact and relevance of their work in the biopharmaceutical sector. These case studies demonstrate the company's ability to develop novel biologics, recombinant protein fusion, bispecific antibodies, and other innovative products that have the potential to address unmet medical needs and improve patient outcomes.
Over the past year, the company has launched several groundbreaking products, including novel biologics, recombinant protein fusion, and bispecific antibodies. They have also entered into strategic partnerships, completed successful funding rounds, and received prestigious awards for their contributions to the biopharmaceutical industry. These key events highlight the company's commitment to innovation, growth, and excellence in the development of advanced therapeutics.
-
Active
Health Care
Life Sciences
Room 301 Gangho Building 6 Ogeum-ro 19-gil Songpa-gu Seoul SL 06735 Korea, Republic Of...
South Korea
425
Yun-Gyeong Bae (Director, Head-Research & Development)
Jung-Chool Kim (Co-Chief Executive Officer & Director)
Jae-Seob Kim (Co-Chief Executive Officer & Director)
Sung-Ho Kang (MD & Head-Pharmaceutical Business Development)
87.36 B
768
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care
Life Sciences
Room 301 Gangho Building 6 Ogeum-ro 19-gil Songpa-gu Seoul SL 06735 Korea, Republic Of...
South Korea
425+
87.36 B
Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical Business and Bio Business divisions. The Pharmaceutical Business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio Business division manufactures biopharmaceuticals.
The company was founded on December 3, 1960 and is headquartered in Seoul, South Korea.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC